Abstract
The current work aimed to propose a system of scoring to rationalize and support the selection of the optimal diameter and length of needles. Four formulations at different viscosity and needles ranging from 21 to 26 G and length ranging from 16 to 40 mm were used. Plunger-stopper breakloose force, maximum force (F max), and dynamic glide force were measured by a texture analyzer at the crosshead speed of 1 mm/s. Testing was carried out into air or human subcutaneous tissue. The manual injectability of the highest viscosity product was assessed by ten evaluators. The comparison of the panel test score and the quantitative measurements of the forces permitted to score a given needle-syringe-formulation system keeping also in consideration the pressure created in the subcutaneous space and muscles at the injection site. In particular, the following relationship was drawn: at the F max up to 250 mPa, the injection was practically impossible; at F max ranging from 160 to 250 mPa, the injection was very difficult; at F max in the 125–160 mPa range, the injection was feasible, though with some difficulty; when the values of F max were lower 125 mPa, the injection went smoothly. On the basis of these preliminary data, a system of scoring the needle-syringe-formulation system is proposed to rationalize and support the selection of the optimal diameter and length of needles, keeping also in consideration the pressure created in the subcutaneous space and muscles at the injection site.
Similar content being viewed by others
References
Groves MJ. Parenteral Technology Manual. Interpharm Press. 1988;9:99–100.
Veldhuis G, Gironès M, Bingham D. Monodisperse microspheres for parenteral drug delivery. Drug Deliv Tech. 2009;9(1):24–31.
Kumar R, Palmieri MJ. Points to consider when establishing drug product specifications for parenteral microspheres. AAPS J. 2010;12:27–32.
Overcashier DE, Chan EK, Hsu CC. Technical considerations in the development of prefilled syringes for protein products. Am Pharm Rev. 2006;9(7):77–83.
Jaber A, Bozzato GB, Vedrine L, Prais WA, Berube J, Laurent PE. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis. BMC Neurol. 2008;8:38.
EMEA, ICH Q6A, Note for Guidance Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (CPMP/ICH/367/96), May 2000.
FDA, CDER, Guidance for Industry Container Closure System for Packaging Human Drugs and Biologics, May 1999.
Ritschel WA, Suzuki K. In vitro testing of injectability. Pharm Ind. 1979;41:468–75.
Capes DF, Herring D, Sunderland VB, McMillan D, McDonald C. The effect on syringe performance of fluid storage and repeated use: implications for syringe pumps. PDA J Pharm Sci Technol. 1996;50(1):40–50.
Dexter MB, Schott MJ. The evaluation of the force to expel oily injection vehicles from syringes. J Pharm Pharmacol. 1979;31:497–500.
Allahham A, Stewart P, Marriott J, Mainwaring DE. Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer. Int J Pharm. 2004;270:139–48.
Allahham A, Mainwaring DE, Stewart P, Marriott J. Development and application of a micro-capillary rheometer for in-vitro evaluation of parenteral injectability. J Pharm Pharmacol. 2004;56:709–16.
Chien YW, Przybyszewski P, Shami EG. Syringeability of nonaqueous parenteral formulations – development and evaluation of a testing apparatus. J Parenter Sci Technol. 1981;35(6):281–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Lavinia Lewis, Jim Agalloco, Bill Lambert, Russell Madsen, and Mark Staples
An erratum to this article is available at http://dx.doi.org/10.1208/s12249-016-0585-0.
Rights and permissions
About this article
Cite this article
Cilurzo, F., Selmin, F., Minghetti, P. et al. Injectability Evaluation: An Open Issue. AAPS PharmSciTech 12, 604–609 (2011). https://doi.org/10.1208/s12249-011-9625-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-011-9625-y